{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:14:12Z","timestamp":1785539652436,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.oret.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:51:10Z","timestamp":1782492670000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statin Intensity and the Risk of Noninfectious Uveitis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2830-9832","authenticated-orcid":false,"given":"Jawad","family":"Muayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-7089","authenticated-orcid":false,"given":"Muhammad Z.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1025-4765","authenticated-orcid":false,"given":"Fahad R.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-3162","authenticated-orcid":false,"given":"Brendan K.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami S.","family":"Dahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed B.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.06.021_bib1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","article-title":"Prevalence of noninfectious uveitis in the United States: a claims-based analysis","volume":"134","author":"Thorne","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib2","article-title":"Epidemiology and risk factors in non-infectious uveitis: a systematic review","volume":"8","author":"Joltikov","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oret.2026.06.021_bib3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.oret.2026.06.021_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2024.1412930","article-title":"Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond","volume":"4","author":"Chauhan","year":"2024","journal-title":"Front Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbj.2017.01.006","article-title":"Statins as anti-inflammatory agents: a potential therapeutic role in sight-threatening non-infectious uveitis","volume":"2","author":"Gilbert","year":"2017","journal-title":"Porto Biomed J"},{"key":"10.1016\/j.oret.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.exer.2006.11.011","article-title":"Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin","volume":"84","author":"Kohno","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oret.2026.06.021_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bjo.2004.050401","article-title":"The effects of atorvastatin in experimental autoimmune uveitis","volume":"89","author":"Thomas","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib9","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s00417-021-05243-8","article-title":"Decreased risk of non-infectious anterior uveitis with statin therapy in a large healthcare claims database","volume":"259","author":"Sobrin","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1869-5760-3-8","article-title":"Statin use and ocular inflammatory disease risk","volume":"3","author":"Yunker","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.oret.2026.06.021_bib11","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s10753-022-01713-1","article-title":"Fenofibrate downregulates NF-\u03baB signaling to inhibit pro-inflammatory cytokine secretion in human THP-1 macrophages and during primary biliary cholangitis","volume":"45","author":"Gallucci","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.oret.2026.06.021_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2025.10.009","article-title":"Association of statin use and noninfectious uveitis: a systematic review and meta-analysis","author":"Tao","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2026.06.021_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajo.2015.01.009","article-title":"Association between statin use and uveitis: results from the Pacific Ocular Inflammation study","volume":"159","author":"Borkar","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.06.021_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41584-024-01189-3","article-title":"HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity","volume":"21","author":"Navid","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.oret.2026.06.021_bib15","article-title":"The Immunopathogenesis of uveitis","volume":"13","author":"Han","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oret.2026.06.021_bib16","article-title":"Corticosteroid implants for chronic non-infectious uveitis","volume":"2","author":"Brady","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oret.2026.06.021_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/02713683.2017.1355468","article-title":"Simvastatin as an adjunct to conventional therapy of non-infectious uveitis: a randomized, open-label pilot study","volume":"42","author":"Shirinsky","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2026.06.021_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","article-title":"Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis","volume":"18","author":"Toth","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.oret.2026.06.021_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/glx169","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.oret.2026.06.021_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamacardio.2017.0911","article-title":"Adherence to high-intensity statins following a myocardial infarction hospitalization among Medicare beneficiaries","volume":"2","author":"Colantonio","year":"2017","journal-title":"JAMA Cardiol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:28:05Z","timestamp":1785529685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S2468653026003131"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.06.021","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin Intensity and the Risk of Noninfectious Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}